STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal
June 07, 2024 08:15 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., June 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...
Wearable Devices Announces $10 Million Standby Equity Purchase Agreement
June 07, 2024 08:05 ET
|
Wearable Devices Ltd.
YOKNEAM ILLIT, ISRAEL, June 07, 2024 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial...
Marucci & Victus Brands to Become the Official Bats of Major League Baseball
June 07, 2024 08:00 ET
|
Fox Factory Holding Corp.
BATON ROUGE, La., June 07, 2024 (GLOBE NEWSWIRE) -- Marucci Sports LLC, a wholly owned subsidiary of Fox Factory Holding Corp. (Nasdaq: FOXF), announced today that it has entered into a license...
Hurco Reports Second Quarter Results for Fiscal Year 2024
June 07, 2024 08:00 ET
|
Hurco Companies, Inc.
INDIANAPOLIS, June 07, 2024 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the second fiscal quarter ended April 30, 2024. Hurco recorded a net loss of...
ODDITY Tech Announces Share Buyback Plan, Raises Q2 Guidance
June 07, 2024 08:00 ET
|
Oddity Tech Ltd.
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that its Board of Directors has approved a share buyback program authorizing the repurchasing on the open...
Solidion Technology Reports Results for Q1 2024
June 07, 2024 08:00 ET
|
Solidion Technology, Inc.
Solidion Technology Reports Results for Q1 2024
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 07, 2024 08:00 ET
|
Replimune Group Inc
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic...
Oxford Lane Capital Corp. Provides May Net Asset Value Update
June 07, 2024 08:00 ET
|
Oxford Lane Capital Corp.
GREENWICH, Conn., June 07, 2024 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS:...
Gorilla Announces $12 Million Registered Direct Offering
June 07, 2024 08:00 ET
|
Gorilla Technology Group Inc.
LONDON, June 07, 2024 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR), a global solution provider in Security Intelligence, Network Intelligence,...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024 08:00 ET
|
Taysha Gene Therapies, Inc.
DALLAS, June 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies...